Showing results (191-200 of 199) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Cancer|June 1, 1982
Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.Medical and Pediatric Oncology|January 1, 1975
The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myelomaJ Cuttner, L R Wasserman, G Martz, et al.Breast Cancer Research and Treatment|June 29, 2002
Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancerA Buzdar, D Hayes, A El-Khoudary, et al.Cancer|January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, L A Leone, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetateP Dombernowsky, I Smith, G Falkson, et al.Cancer|February 1, 1978
Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapseF H Kung, W L Nythan, J Cuttner, et al.Cancer|August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.Cancer|January 1, 1979
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, O Glidewell, et al.Blood|August 1, 1982
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB studyJ Yates, O Glidewell, P Wiernik, et al.Pageof 20